Search Results 2721-2730 of 34572 for oral
John M. Nathan, M.D., D.D.S.. Sleep Medicine Specialist; Oral and Maxillofacial Surgeon; Surgeon. Rochester, MN ...
This is a 52-week open-label study to evaluate the safety and tolerability of ADS-5102 oral capsules, an extended release formulation of amantadine, in ...
CoordinatorResident Oral Exam Simulation, Department of Anesthesiology and Perioperative Medicine. 2016 - present. ChairSouth Division, Department of ...
Oral Session ModeratorAnnual Meeting, Malignant Conditions (Myeloid) Quality of Life, Late Effects and Prognostic Factors in Myeloid Disease Session ...
Oral prednisone ≥ 40 mg/day (or equivalent) or budesonide ≥ 9 mg/day or equivalent or beclomethasone ≥ 5 mg/day for at least 2 weeks;; Immunomodulators ...
Use of oral corticosteroids and unable or unwilling to stop use of oral corticosteroids within the previous 6 weeks and for the duration of the study.
Oral and Maxillofacial Surgeon. Rochester, MN. Areas of focus: Dental implant surgery, Jaw surgery, Maxillary osteotomy, Mandibular osteotomy, Mandibular ...
Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Sleep Medicine in Minnesota · Psychiatry and Psychology · Sleep Medicine ...
Continuous daily use of oral prednisone or oral dexamethasone for more than 14 days within 3 months prior to study; Received prior chemotherapy for prostate ...
2012. ExaminerMusculoskeletal Oral Boards, American Board of Radiology. 2012. DirectorOrthopedic Practice Society Annual Meeting. 2010 - present. Committee ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.